MedTrace Logo

Evaluating a Digital Health Information Tool

NCT02549599 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5220

Last updated 2022-10-27

No results posted yet for this study

Summary

The primary aim of the proposed project is to conduct a randomized controlled trial to evaluate the efficacy of a digital intervention tool that enables young people to correspond with trained staff via online chat or text messages about urgent questions related to sexual/reproductive health.

Conditions

  • Behavior and Behavior Mechanisms

Interventions

BEHAVIORAL

Chat/Text Program

Participants will receive access to the Chat/Text program on the internet via computer or mobile device. The Chat/Text program involves interactive, immediate, and tailored messages (with pre-determined content) delivered by Chat/Text agents via online chat or mobile phone text. At the conclusion of the session, the participants will receive a combination-baseline and follow-up survey.

BEHAVIORAL

Website Content

Participants will be directed to content and information on the Planned Parenthood website. The website contains information on birth control methods, locations of Planned Parenthood health clinics, and on sexual and reproductive health more broadly.

OTHER

Delayed Treatment

Participants will receive a baseline survey and be routed to the Planned Parenthood website. No subsequent survey will be administered

Sponsors & Collaborators

  • Planned Parenthood Federation of America

    collaborator OTHER

  • New York University

    lead OTHER

Principal Investigators

  • Vincent Guilamo-Ramos, PhD, MPH, LCSW, RN · New York University

  • Leslie Kantor, PhD, MPH · Planned Parenthood Federation of America

  • James Jaccard, PhD · New York University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
25 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2016-01-31
Completion
2016-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02549599 on ClinicalTrials.gov